Blog — metabolic syndrome

What is Cardiometabolic Risk?

Posted by Behcet Bicakci on

What is Cardiometabolic Risk? Cardiometabolic risk refers to a collection of conditions linked to obesity and insulin resistance that increase the chances of developing type 2 diabetes, heart disease, or both. These risks rarely occur in isolation—when one appears, others often follow. That’s why proactive screening is so important.

Read more →


Understanding Cardio Metabolic Risk – A Silent Threat We Can’t Ignore

Posted by Behcet Bicakci on

Title: Understanding CardioMetabolic Risk – A Silent Threat We Can’t Ignore The rise in cardiovascular disease (CVD), obesity, and type 2 diabetes (DM2) is one of the most pressing health concerns of our time. CVD remains the leading cause of death for both men and women in the United States. Alarmingly, obesity and insulin resistance—precursors to DM2—significantly increase the risk of developing CVD. Yet, these conditions are largely preventable with early detection and lifestyle changes. So, how can we spot the danger before it's too late? What is CardioMetabolic Risk? Cardiometabolic risk refers to a cluster of modifiable risk factors...

Read more →


The Obesity Epidemic in the UK – A Hormonal Perspective on a Growing Crisis

Posted by Behcet Bicakci on

The UK is facing a growing obesity crisis, with two-thirds of adults and a rising number of children classified as overweight or obese. A recent UK Parliament briefing highlights alarming trends, including regional and ethnic disparities and increased risks linked to socioeconomic status. While public health strategies continue to evolve, addressing the hormonal root of weight gain may offer a more effective, personalized solution. ZRT Laboratory’s Weight Management Profile helps uncover hidden hormonal imbalances—such as elevated cortisol, low testosterone, or thyroid dysfunction—that contribute to stubborn fat gain, poor metabolism, and increased disease risk.

Read more →


The Interplay of Metabolic Health, Hormones, and NAFLD

Posted by Behcet Bicakci on

By Dr.Tracy Tranchitella, ND-ZRT Laboratory Non-Alcoholic Fatty Liver Disease (NAFLD) has become a primary cause of chronic liver disease, impacting a large portion of the global population. NAFLD is characterized by the buildup of excess fat in the liver, unrelated to alcohol use, and is strongly associated with metabolic syndrome—a group of conditions that raise the risk of heart disease, stroke, and diabetes. Factors contributing to metabolic syndrome may also play a role in the development of NAFLD, but underlying endocrine disorders can further drive the onset and progression of this widespread liver condition. Moreover, environmental and chemical toxins may...

Read more →


Fertility Mapping: Navigating Fertility with PCOS and Insulin Resistance (Part II)

Posted by Behcet Bicakci on

Fertility Mapping: Navigating Fertility with PCOS and Insulin Resistance (Part II)By Dr. Alison McAllister Polycystic Ovary Syndrome (PCOS) is a complex, multifactorial condition influenced by disruptions in hormone receptors, metabolism, neurotransmitter function, and nutrient balance. As a lifelong disorder, PCOS is a leading contributor to infertility, weight gain, and an increased risk for cardiometabolic issues. In this blog post, we dive deeper into laboratory testing, helping healthcare providers understand which tests are critical for women suspected of having PCOS. Lab Testing for PCOS PCOS is most commonly diagnosed through the Rotterdam Criteria, a diagnostic framework that considers various indicators, including...

Read more →